A trial of acupuncture for nerve damage symptoms that chemotherapy can cause (ACUFOCIN)
Cancer type:
Status:
Phase:
This trial looked at acupuncture and usual treatment for a type of nerve damage. This nerve damage is called peripheral neuropathy and chemotherapy can cause it.
One of the side effects of chemotherapy can be peripheral neuropathy. This can cause nerve pain and loss of feeling. It may also affect balance. It most often affects the feet and hands. But it might also cause problems with nerves elsewhere in the body.
This trial was for people who had 1 of the following types of cancer:
- a type of blood cancer called myeloma
- breast cancer
gastro intestinal cancer such as stomach cancer
- ovarian cancer
The trial was open for people to join between 2015 and 2018. The team presented the results at a conference in 2020.
More about this trial
The symptoms of might cause problems with fine movements in the hands and feet. For example doing up buttons can be very difficult. The symptoms can:
- lead to treatment delays
- affect
quality of life
Peripheral neuropathy can get better but in some people these symptoms don’t improve.
When the researchers did this trial the usual treatment for nerve damage was drugs to help with feeling. These drugs included gabapentin, amitriptyline, pregabalin and some creams and gels. These helped but doctors wanted to improve treatment for this group of people.
In this trial they looked at acupuncture alongside the usual treatments. Acupuncture is a . It uses fine sterile needles which are put just under the skin at certain points on the body. There was some evidence at the time that acupuncture could help with peripheral neuropathy symptoms such as pain.
The aim of this trial was to see if acupuncture improves the symptoms of peripheral neuropathy.
Summary of results
The trial team found that adding acupuncture to usual treatment helped. It improved the symptoms of nerve damage caused by chemotherapy.
Trial design
120 people took part in the trial:
- 61 people had breast cancer
- 9 people had myeloma
- 48 people had
gastro intestinal cancer such as stomach or bowel cancer
- 2 people had ovarian cancer
The trial included people:
- who had moderate to severe nerve damage (peripheral neuropathy) caused by chemotherapy
- whose peripheral neuropathy symptoms were troublesome and affected their quality of life
Everyone taking part rated the symptoms that bothered them the most. They used a measure called the Measure Yourself Medical Outcome Profile (MYMOP 2 score). This was on a scale from 0 to 6. They could join if their symptoms were quite bad. This meant having a score from 3 to 6.
Before the trial started:
- 33 people had a score of 3 or 4 (28%)
- 87 people had a score of 5 or 6 (73%)
The trial doctor also rated how bad the nerve damage was before treatment started. They found:
- in 103 people this was moderate
- in 17 people this was bad to severe
The people taking part were put into a treatment group at random:
- half had usual treatment
- half had usual treatment and acupuncture
Everyone had treatment as usual for peripheral neuropathy. The type they had depended on their specific symptoms.
Those having acupuncture had 10 sessions with a trained acupuncturist. The sessions took place once a week. The treatment period was 10 weeks.
Results
The team looked at how well treatment worked. They had the results for 108 people. Of those:
- 54 had usual treatment and acupuncture
- 56 had usual treatment
Acupuncture treatment ended at week 10. At this timepoint, the trial doctors reported if the nerve damage was mild, moderate or severe. They found the nerve damage symptoms had improved in:
- 27 out of 53 people who had acupuncture and usual treatment (51%)
- 4 out of 56 people who had usual treatment alone (7%)
At the same timepoint (10 weeks), the team looked to see whose symptoms score had improved by 2 points or more. This was a patient reported outcome measure or PROM. This looked at how patients rated their own symptoms.
They found this happened in:
- 36 out of 54 people who had acupuncture and usual treatment (67%)
- 18 out of 55 people who had usual treatment alone (33%)
Quality of life and pain scores
Everyone filled in a questionnaire before starting treatment and several times during the trial. The questionnaire asked about side effects and how they had been feeling. This is called a .
The team looked at how people rated their quality of life. When treatment finished, they found people who had had acupuncture reported a better quality of life.
Everyone taking part also kept a pain diary. They recorded their pain levels once a week on a pain scale. This was on a scale from 0 to 10. A score of 0 means no pain at all and 10 means the worst pain you can imagine.
At week 10 the team looked to see if people’s pain levels had changed. Those who had acupuncture reported their pain was much better compared to those who had only usual care.
Conclusion
The team found that in this small trial adding a 10 week course of acupuncture to usual treatment helped. It improved the symptoms of peripheral neuropathy that chemotherapy can cause.
Where this information comes from
We have based this summary on information from the research team. The information they sent us has been reviewed by independent specialists () but may not have been published in a medical journal. The figures we quote above were provided by the research team. We have not analysed the data ourselves.
Recruitment start:
Recruitment end:
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Chief Investigator
Prof Andrew Wardley
Supported by
Manchester Clinical Trials Unit (MCTU)
National Institute for Health Research (NIHR)
NIHR Clinical Research Network: Cancer
The Christie NHS Foundation Trust
If you have questions about the trial please contact our cancer information nurses
Freephone 0808 800 4040